About RDD Pharma
RDD Pharma is a company based in Tel Aviv (Israel) founded in 2008 was acquired by Innovate Biopharma in October 2019.. RDD Pharma has raised $16.65 million across 3 funding rounds from investors including PharmaScience, Orbimed and Innovate Biopharma. RDD Pharma offers products and services including Capository, Treatment for Fecal Incontinence, and Treatment for Pruritus Ani. RDD Pharma operates in a competitive market with competitors including Ironwood Pharma, RedHill Biopharma, Alcresta, Seed and Ardelyx, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rdd Pharma, Ltd
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.65 M (USD)
in 3 rounds
-
Latest Funding Round
$9.5 M (USD), Series B
Nov 16, 2017
-
Investors
PharmaScience
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Innovate Biopharma
(Oct 07, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RDD Pharma
RDD Pharma offers a comprehensive portfolio of products and services, including Capository, Treatment for Fecal Incontinence, and Treatment for Pruritus Ani. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Proprietary system for targeted delivery of treatments to anorectal regions.
Repurposed drug compound for managing fecal incontinence symptoms.
Repurposed medication targeting pruritus ani and related conditions.
Unlock access to complete
Unlock access to complete
Funding Insights of RDD Pharma
RDD Pharma has successfully raised a total of $16.65M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $9.5 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $9.5M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Series B - RDD Pharma | Valuation |
investors |
|
| Jul, 2012 | Amount | Series A - RDD Pharma | Valuation |
investors |
|
| Jun, 2009 | Amount | Seed - RDD Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RDD Pharma
RDD Pharma has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include PharmaScience, Orbimed and Innovate Biopharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Early-stage real estate startups are funded by Capital Point.
|
Founded Year | Domain | Location | |
|
Generic, branded, and over-the-counter pharmaceuticals are manufactured for global markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RDD Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RDD Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rdd Pharma Comparisons
Competitors of RDD Pharma
RDD Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, RedHill Biopharma, Alcresta, Seed and Ardelyx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| domain | founded_year | HQ Location |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Proprietary therapeutic products for gastrointestinal diseases are developed and marketed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rdd Pharma
Frequently Asked Questions about RDD Pharma
When was RDD Pharma founded?
RDD Pharma was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is RDD Pharma located?
RDD Pharma is headquartered in Tel Aviv, Israel.
Is RDD Pharma a funded company?
RDD Pharma is a funded company, having raised a total of $16.65M across 3 funding rounds to date.
What does RDD Pharma do?
RDD Pharma is a clinical stage company focussed on developing drugs and delivery systems for anorectal and gastrointestinal disorders. It is targeting the space between generics and NCEs to develop its pipeline. It is currently initiating a phase 3 study for the treatment of chronic anal fissure with its lead product RDD 1219 along with a sustained release drug delivery device Capository. It also completed phase 2a study of RDD 0315 for fecal incontinence Pruritus Ani. Besides, it has a preclinical program for Radiation Colitis.
Who are the top competitors of RDD Pharma?
RDD Pharma's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
What products or services does RDD Pharma offer?
RDD Pharma offers Capository, Treatment for Fecal Incontinence, and Treatment for Pruritus Ani.
Who are RDD Pharma's investors?
RDD Pharma has 4 investors. Key investors include PharmaScience, Orbimed, Innovate Biopharma, and Capital Point.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.